Thomas P. Email and Phone Number

- Lead the $5.0B+ Virology, Immunology and New Therapeutic Franchise Finance Team. Execute the forecasting, reporting and analysis of Franchise P&Ls.- Partner with Global Brand Leads to develop product strategies and financial forecasts. Advise on key issues- Present financial forecasts to Executive Committees, communicating key issues and assumptions- Lead financial efforts by working cross-functionally to launch Merck's new COVID-19 oral therapy, Lagevrio- Perform financial evaluation and analyses on new products/ product expansions- Partner with external collaborators including J&J and Gilead on partnered products- Collaborate with supply chain teams, demand forecasters and market access colleagues to ensure proper supply and access- Led transition of work responsibilities to Business Service Center based in Costa Rica

- Human Health Lead responsible for the reporting and analysis of the $35B Consolidated Human Health Business- Provided operational leadership and analytical support to ensure the integrity of Divisional forecasts, Budget and 5-15 Year Plans- Developed and presented materials for Executive Committees, clearly articulating key issues- Led divisional finance projects including Sales Force Efficiency, Innovative Contracting, Standardized Reporting and Automated Commentary- Managed a staff of three professionals

- Led the monthly and quarterly reporting of the Company's consolidated financial results to Executive Management and the Board of Directors. - Presented quarterly results and analysis to the CFO and Investor Relations during earnings release preparation. This included all products, geographies and P&L line item variations.- Partnered with Divisional and Franchise teams to understand the key drivers of company performance and concisely communicated these results to management.- Responsible for SEC reporting requirements for the 10-Q/10-K, including the development of the Management Discussion and Analysis (MD&A) and related footnotes while maintaining strict accordance with GAAP.- Led cross-divisional team to effectively integrate Animal Health company into Merck- Managed a staff of three professionals

- Maintained domestic books for inclusion in monthly and periodic operating reports and government agencies- Prepared accounting for fixed assets, construction-in-progress and royalties due/ receivable.- Prepared the monthly accounting and financial results for a number of Merck small entities.